Toll Free: 1-888-928-9744
Published: Sep, 2014 | Pages:
38 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Five Prime Therapeutics, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Five Prime Therapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Five Prime Therapeutics, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Five Prime Therapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Five Prime Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Five Prime Therapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Five Prime Therapeutics, Inc.'s pipeline products Reasons to buy - Evaluate Five Prime Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Five Prime Therapeutics, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Five Prime Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Five Prime Therapeutics, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Five Prime Therapeutics, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Five Prime Therapeutics, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Five Prime Therapeutics, Inc. Snapshot 5 Five Prime Therapeutics, Inc. Overview 5 Key Information 5 Key Facts 5 Five Prime Therapeutics, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Five Prime Therapeutics, Inc. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Pipeline Products - Partnered Products 11 Partnered Products/Combination Treatment Modalities 12 Pipeline Products - Out-Licensed Products 13 Out-Licensed Products/Combination Treatment Modalities 14 Five Prime Therapeutics, Inc. - Pipeline Products Glance 15 Five Prime Therapeutics, Inc. - Clinical Stage Pipeline Products 15 Phase I Products/Combination Treatment Modalities 15 Five Prime Therapeutics, Inc. - Early Stage Pipeline Products 16 Preclinical Products/Combination Treatment Modalities 16 Discovery Products/Combination Treatment Modalities 17 Five Prime Therapeutics, Inc. - Drug Profiles 18 FP-1039 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 FPA-008 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 FP-1069 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 FPA-144 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Antibodies for Solid Tumors 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Monoclonal Antibodies for Cancer 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 Proteins For Asthma and Chronic Obstructive Pulmonary Disease 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 Proteins for Central Nervous System Disorders 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 Proteins for Fibrosis Related Inflammatory Diseases 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 Five Prime Therapeutics, Inc. - Pipeline Analysis 29 Five Prime Therapeutics, Inc. - Pipeline Products by Target 29 Five Prime Therapeutics, Inc. - Pipeline Products by Route of Administration 30 Five Prime Therapeutics, Inc. - Pipeline Products by Molecule Type 31 Five Prime Therapeutics, Inc. - Pipeline Products by Mechanism of Action 32 Five Prime Therapeutics, Inc. - Recent Pipeline Updates 33 Five Prime Therapeutics, Inc. - Dormant Projects 35 Five Prime Therapeutics, Inc. - Locations And Subsidiaries 36 Head Office 36 Appendix 37 Methodology 37 Coverage 37 Secondary Research 37 Primary Research 37 Expert Panel Validation 37 Contact Us 38 Disclaimer 38
List of Tables Five Prime Therapeutics, Inc., Key Information 5 Five Prime Therapeutics, Inc., Key Facts 5 Five Prime Therapeutics, Inc. - Pipeline by Indication, 2014 8 Five Prime Therapeutics, Inc. - Pipeline by Stage of Development, 2014 9 Five Prime Therapeutics, Inc. - Monotherapy Products in Pipeline, 2014 10 Five Prime Therapeutics, Inc. - Partnered Products in Pipeline, 2014 11 Five Prime Therapeutics, Inc. - Partnered Products/ Combination Treatment Modalities, 2014 12 Five Prime Therapeutics, Inc. - Out-Licensed Products in Pipeline, 2014 13 Five Prime Therapeutics, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2014 14 Five Prime Therapeutics, Inc. - Phase I, 2014 15 Five Prime Therapeutics, Inc. - Preclinical, 2014 16 Five Prime Therapeutics, Inc. - Discovery, 2014 17 Five Prime Therapeutics, Inc. - Pipeline by Target, 2014 29 Five Prime Therapeutics, Inc. - Pipeline by Route of Administration, 2014 30 Five Prime Therapeutics, Inc. - Pipeline by Molecule Type, 2014 31 Five Prime Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2014 32 Five Prime Therapeutics, Inc. - Recent Pipeline Updates, 2014 33 Five Prime Therapeutics, Inc. - - Dormant Developmental Projects,2014 35
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.